Carle Cancer Center NCI Community Oncology Research Program

Urbana, Illinois 61801

We've found

3 trials

at this facility

Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Urbana, IL

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Urbana, IL

A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Urbana, IL

Use our guide to learn which trials are right for you!